Pharma Forum: Oct. 11, 2024

Today we're looking at significant developments in corporate governance, oncology, manufacturing, and strategic acquisitions. Here are the top 5 news stories:

1. Pfizer's Clash with Activist Investor: Pfizer is facing scrutiny from Starboard Value, an activist investor group, accusing the company of pressuring former executives after they initially agreed to meet. This situation highlights corporate governance challenges amid declining share prices. FiercePharma

   
   

2. Roche Strengthens Breast Cancer Portfolio: Roche has secured FDA approval for Itovebi, a new addition to its breast cancer treatment lineup, underscoring the company's expanding oncology portfolio. This approval further reinforces Roche’s position in cancer therapies. FiercePharma

   
   

3. B. Braun Updates on Florida Manufacturing Facility: German-based medical device leader B. Braun provided updates on its Florida facility, which was impacted by Hurricane Milton. The company outlined its recovery plans, aiming to restore IV fluid production​. FiercePharma

   
   

4. Novo Holdings' Bid for Catalent Faces Regulatory Challenge: U.S. Senator Elizabeth Warren is raising concerns over Novo Holdings’ proposed acquisition of Catalent, a prominent contract development and manufacturing organization. The opposition reflects​ on market consolidation in the pharma manufacturing sector. FiercePharma

   
   

5. Scottish CMO Symbiosis Expands Production: Symbiosis, a contract manufacturing organization based in Scotland, is investing £1.2 million to expand its production​. The move is aimed at meeting the growing demand for biotech manufacturing services. FiercePharma

Contact me for custom reports to help your specific business needs.